Professor Edward Byrne
REGISTERHISTORYCOMMITTEESTATEMENTSCONTACTLINKS
Edward Byrne
Click to view my profile Click to view my profile Click to view my profile Click to view my profile
Click to view my profile Click to view my profile Click to view my profile Click to view my profile
Click to view my profile Click to view my profile Click to view my profile

Prof Edward BYRNE

Professor Ed Byrne has had an active career in clinical neurology and basic neurological research. Professor Byrne received his MBBS with first class honours from the University of Tasmania in 1974. He moved to Adelaide the following year and became Neurology Registrar in 1978. During the years 1980 – 1982, he was the Muscular Dystrophy Research Fellow at Queen Square in London. In 1983, he returned to Australia as the Director of Neurology at St Vincent’s Hospital Melbourne and from 1992, was Professor/Director. He was awarded the degree of Doctor of Science from the University of Melbourne in 1995. Professor Byrne was also the Founding Director of the Melbourne Neuromuscular Research Institute. He was the Founding Director of the Centre for Neuroscience and Professor of Experimental Neurology at the University of Melbourne. As Director of the Centre for Neuroscience, he played a major role in driving the establishment of Neurosciences Victoria and Neurosciences Australia. His research group has made significant contributions in muscular dystrophy and mitochondrial research. He is a board member of Cochlear Pty Ltd, Neurosciences Australia and Neurosciences Victoria and was Editor-in-Chief of the Internal Medicine Journal. He is a member of the Neuromuscular Steering Group of the World Federation of Neurology and was Secretary General and Chair of the program committee of the 9th International Neuromuscular Congress.

Professor Ed Byrne is now Dean of Medicine Nursing and Health Sciences at Monash University.

 


REGISTERHISTORYCOMMITTEESTATEMENTSCONTACTLINKS

 

DisclaimerPrivacy                                             INDAPS is sponsored by an unrestricted educational grant from CSL Biotherapies

Professor Edward Byrne